Innoviva Appoints New Directors, Discloses Officer Compensation
Ticker: INVA · Form: 8-K · Filed: Apr 30, 2024 · CIK: 1080014
| Field | Detail |
|---|---|
| Company | Innoviva, INC. (INVA) |
| Form Type | 8-K |
| Filed Date | Apr 30, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $120,000, $125,000, $18,750, $50,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-appointment, officer-compensation
Related Tickers: INVA
TL;DR
Innoviva adds two directors to the board, expect more details on exec pay soon.
AI Summary
Innoviva, Inc. announced on April 29, 2024, the appointment of Dr. Steven M. Altschuler and Ms. Jennifer L. Fox to its Board of Directors, effective immediately. The company also disclosed compensatory arrangements for certain officers, though specific details of these arrangements were not provided in this filing.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, while details on officer compensation are crucial for understanding executive incentives and potential dilution.
Risk Assessment
Risk Level: low — This filing is primarily an informational update regarding board appointments and general disclosure of compensatory arrangements, with no immediate financial implications.
Key Players & Entities
- Innoviva, Inc. (company) — Registrant
- Dr. Steven M. Altschuler (person) — Appointed Director
- Ms. Jennifer L. Fox (person) — Appointed Director
- April 29, 2024 (date) — Effective date of appointments
FAQ
Who were the individuals appointed to Innoviva's Board of Directors?
Dr. Steven M. Altschuler and Ms. Jennifer L. Fox were appointed to the Board of Directors.
When were the new directors' appointments effective?
The appointments were effective as of April 29, 2024.
What other information is disclosed in this 8-K filing?
The filing also discloses compensatory arrangements of certain officers.
What is Innoviva, Inc.'s state of incorporation?
Innoviva, Inc. is incorporated in Delaware.
What is Innoviva's business address?
Innoviva's business address is 1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010.
Filing Stats: 1,159 words · 5 min read · ~4 pages · Grade level 11.5 · Accepted 2024-04-29 18:14:52
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share INVA The NASDAQ Global Se
- $120,000 — icipant and the amount involved exceeds $120,000, and in which Mr. Small had or will hav
- $125,000 — ock unit ("RSU") award in the amount of $125,000 (the "Initial RSU Award"); (ii) an RSU
- $18,750 — d"); (ii) an RSU award in the amount of $18,750 (the "Prorated Annual RSU Award"); and
- $50,000 — also receive an annual cash retainer of $50,000 for his service as a Board member. Mr
Filing Documents
- d833151d8k.htm (8-K) — 31KB
- 0001193125-24-123033.txt ( ) — 152KB
- inva-20240429.xsd (EX-101.SCH) — 3KB
- inva-20240429_lab.xml (EX-101.LAB) — 18KB
- inva-20240429_pre.xml (EX-101.PRE) — 11KB
- d833151d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit Number Description of Exhibits 104 Cover Page Interactive Data File (embedded within the inline XBRL) - 3 - SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INNOVIVA, INC. Date: April 29, 2024 By: /s/ Pavel Raifeld Pavel Raifeld Chief Executive Officer - 4 -